Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells


Journal of Cancer Metastasis and Treatment Citation Report in 2018

Published on: 22 Feb 2019 Viewed: 2088

We know that many editors, authors, reviewers, and readers are very concerned about the impact of Journal of Cancer Metastasis and Treatment (JCMT). Then we hereby report the citations of the journal articles. In total, JCMT published 67 and 41 articles in 2016 and 2017, respectively. Among them, 63 and 35 were Review, Original article or Case report in 2016 and 2017, respectively. 31 of these articles were cited 67 times in 2018 by articles indexed in Web of Science (as of January 21, 2019). All the cited articles are listed below.

This is a great proof of our efforts. We believe that we will become better in 2019! Our editorial office expects that more researchers would join us for the growth of JCMT.

Article titleAuthorsPublication YearCited timesCited byDOI
A new twist to neurotransmitter receptors and cancerSchuller, H. M.20171Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember
Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic interventionPippione, A. C.; Boschi, D.; Pors, K.; Oliaro-Bosso, S.; Lolli, M. L.20171Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
Brain tumor surgery: supplemental intra-operative imaging techniques and future challengesBelsuzarri, T. B.; Sangenis, R. A.; Araujo, J. M.20161In-vivo Raman spectroscopy: from basics to applications
Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgeryYagawa, Y.; Tanigawa, K.; Kobayashi, Y.; Yamamoto, M.20172The Potential of Intrinsically Magnetic Mesenchymal Stem Cells for Tissue Engineering
    Magnetic Hyperthermia and Radiation Therapy: Radiobiological Principles and Current Practice
Changing paradigm in treatment of lung cancerViswanath, S; Pathak, A; Kapoor, A; Rathore, A; Kapur, BN20161Design and validation of a CT‐guided robotic system for lung cancer brachytherapy
Circulating neuroendocrine tumors biomarkers. Why? When? How? Suggestions for clinical practice from guidelines and consensusRazzore, P; Arnaldi, G.20162Neuroendocrine Tumors Biomarkers
    Neuroendocrine neoplasia goes molecular — time for a change
Cytogenetic and molecular basis of BCR-ABL myelodysplastic syndrome: diagnosis and prognostic approachParidar, M.; Ghalesardi, O. K.; Seghatoleslami, M.; Ahmadzadeh, A.; Khosravi, A.; Saki, N.20172Philadelphia Translocation in MDS: A Case Report and a Brief Review of the Literature Looking at Its Prevalence, Disease Progression, and Treatment Options
    De Novo Philadelphia Chromosome (BCR/ABL1) Positive Myelodysplastic Syndrome: Is it a Distinct Molecular and Clinical Entity?
Dissecting brain tumor growth and metastasis in vitro and ex vivoGrotzer, M. A.; Neve, A.; Baumgartner, M.20162Genetically engineered cerebral organoids model brain tumor formation
    Integrating in vitro experiments with in silico approaches for Glioblastoma invasion: the role of cell-to-cell adhesion heterogeneity
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progressionWang, Wei; Mani, Arul M; Wu, Zhao-Hui20177An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-kappa B Signaling
    Targeting IKK beta in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKK beta Inhibitors
    CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis
    Survivin Inhibitors Mitigate Chemotherapeutic Resistance in Breast Cancer Cells by Suppressing Genotoxic Nuclear Factor-kappa B Activation
    NF-kappa B, inflammation, immunity and cancer: coming of age
    Treating patients suffering from myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) with sodium dichloroacetate: An open-label, proof-of-principle pilot trial
    Atrophied Thymus, a Tumor Reservoir for Harboring Melanoma Cells
Do elderly NSCLC stage IV patients benefit from chemotherapy as well as younger? An analysis from clinical practice dateGirones,, R.; Lopez,, P.; Chulvi,, R.; Canabate,, M.20161Geriatric assessment in clinical practice for patients with stage IV non‐small‐cell lung cancer: The Grup de Investigació I Divulgació Oncològica experience
Evaluation of anti-metastatic effect of chitosan nanoparticles on esophageal cancer-associated fibroblastsPotdar, P. D.; Shetti, A. U.20161Competitive Biological Activities of Chitosan and Its Derivatives: Antimicrobial, Antioxidant, Anticancer, and Anti-Inflammatory Activities
Function of cancer cell-derived extracellular matrix in tumor progressionXiong, G.- F.; Xu, R.201610A Systems Biology Approach to Understanding the Pathophysiology of High-Grade Serous Ovarian Cancer: Focus on Iron and Fatty Acid Metabolism
    Chemoresistance and the Self-Maintaining Tumor Microenvironment
    Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis
    TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction
    Glass transition in temperature-responsive poly(butyl methacrylate) grafted polymer brushes. Impact of thickness and temperature on wetting, morphology, and cell growth
    Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence
    Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance
    Carbon‐Based Nanomaterials for Cancer Therapy via Targeting Tumor Microenvironment
    Tumor Microenvironment Targeted Nanotherapy
    3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Hepatocellular carcinoma presenting as rapidly growing sternal mass: an unusual presentationKulkarni, RS; Anand, AS; Patel, AA; Shah, SA20161Pure hepatocellular carcinoma originates from an ectopic liver nodule located in the pancreas
    Clinical Implications of Transbronchial Biopsy for Surgically-resected Non-small Cell Lung Cancer
    Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Management of hepatic metastases of well/moderately differentiated neuroendocrine tumors of the digestive tractSalvia, AL; Partelli, S; Tampellini, M; Tamburrino, D; Falconi, M; Scagliotti, GV20163Transarterial chemoembolization in pancreatic adenocarcinoma with liver metastases: MR-based tumor response evaluation, apparent diffusion coefficient (ADC) patterns, and survival rates
    Retreatment with peptide receptor radionuclide therapy in patients with progressing neuroendocrine tumours: efficacy and prognostic factors for response
    Surgical management of neuroendocrine tumor-associated liver metastases: a review
Molecular and cellular aspects of extramedullary manifestations of acute myeloid leukemiaMohammadiasl, J; Khosravi, A; Shahjahani, M; Azizidoost, S; Saki, N20161Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration
Nanocarrier Drugs in the Treatment of Brain TumorsCerna, T.; Stiborova, M.; Adam, V.; Kizek, R.; Eckschlager, T.20163Envisioning the future of polymer therapeutics for brain disorders
    Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
    Nanoparticles based on disulfide-containing poly(β-amino ester) and zwitterionic fluorocarbon surfactant as a redox-responsive drug carrier for brain tumor treatment
Osteonecrosis of the jaw in a patient with acute myeloid leukemia, who received azacitidineNicolatou-Galitis,, O.; Galiti,, D.; Moschogianni,, M.; Sachanas,, S.; Edwards,, B. J.; Migliorati,, C. A.; Pangalis,, G.20162Risk factors for medication‐related osteonecrosis of the jaws: A systematic review
    Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention
Oxidative stress and breast cancer biomarkers: the case of the cytochrome P450 2E1Singh, S.; Rajendran, R.; Kuroda, K.; Isogai, E.; Krstic-Demonacos, M.; Demonacos, C.20161ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications
Profiling of circulating tumor cells in liquid biopsies from metastatic cancer patientsPotdar, P. D.; Sen, K.20171A Multiwell-Based Detection Platform with Integrated PDMS Concentrators for Rapid Multiplexed Enzymatic Assays
Real-time quantitative PCR array to study drug-induced changes of gene expression in tumor cell linesAmatori, S.; Persico, G.; Fanelli, M.20171c-Myc is a novel Leishmania virulence factor by proxy that targets the host miRNA system and is essential for survival in human macrophages
Role of adenosine in tumor progression: focus on A2B-receptor as potential therapeutic targetSorrentino, C; Morello, S.20171Radiosynthesis and in vivo evaluation of a fluorine-18 labeled pyrazine based radioligand for PET imaging of the adenosine A(2B) receptor
Roles of dysregulated Notch pathway and small DNA tumor viruses in cancer initiation and progressionClementz, AG; Rizzo, P; Martini, F; Tognon, M.20161New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
Tailored nanocarriers and bioconjugates for combating glioblastoma and other brain tumorsOthman, AA; Adkins, C; Helmy, A; Nounou, MI20161Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges
Targeting cerebrospinal fluid for discovery of brain cancer biomarkersShalaby, T; Achini, F; Grotzer, MA20165MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study
    Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma
    Detection of central nervous system infiltration by Myeloid and lymphoid hematologic neoplasms Using Flow cytometry analysis: Diagnostic accuracy study
    Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors
    Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications
Targeting Toll-like receptors against cancerDu, B.; Jiang, Q.-L.; Cleveland, J.; Liu, B.-R.; Zhang, D.20162Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
    Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
TGF-beta Stimulation of EMT Programs Elicits Non-genomic ER-alpha Activity and Anti-estrogen Resistance in Breast Cancer CellsTian, Maozhen; Schiemann, William P20173Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer
    Molecular Signatures of the Insulin-Like Growth Factor 1-Mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers
    Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
The features of peritoneal metastases from gastric cancerGianni Mura, BV20161Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer
The role of the PI3K/AKT/mTOR pathway in brain tumor metastasisCrespo, S.; Kind, M.; Arcaro, A.20164A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
    KT2 and RT2 modified antimicrobial peptides derived from Crocodylus siamensis Leucrocin I show activity against human colon cancer HCT-116 cells
    Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks
    Emerging findings into molecular mechanism of brain metastasis
Therapeutic strategies for targeting cancer stem cellsKim, YJ; Siegler, EL; Siriwon, N; Wang, P20161Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
What we have learned from urinary bladder cancer modelsBernardo, C; Costa, C; Palmeira, C20161Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties